XML 55 R37.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Aug. 10, 2021
Jul. 26, 2021
May 26, 2021
Apr. 29, 2021
Feb. 25, 2021
Jan. 02, 2021
Feb. 25, 2020
Jan. 02, 2017
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Subsidiary, Sale of Stock [Line Items]                        
Proceeds from Issuance Initial Public Offering       $ 11,700,000                
Stock options outstanding                     5,520,861 5,597,861
Stock options outstanding weighted average exercise price                     $ 1.84 $ 1.47
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value                     $ 430,174  
Number of option shares issued                     583,000  
Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price                     $ 4.77  
Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term                     6 years 5 months 23 days  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares                     635,500  
Stock issued during the period exercised                     370,000  
Commom stock issued                 360,000   17,209,612 10,360,480
Proceeds from Stock Options Exercised                 $ 532,500      
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number                     6,132,630 4,007,058
Warrants outstanding                 836,558 240,123    
Proceeds from warrants exercised                 $ 300,000      
Options To Related Party [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Stock options outstanding                   10,000    
Stock options outstanding weighted average exercise price                   $ 1.00    
Stock issued during the period exercised                   10,000    
Warrants outstanding                 231,277      
2016 Plan [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Number of additional shares grants for issuance           569,826   564,378        
Number of shares available for grant               1,693,134     5,438,449 4,868,623
Series B Prefered Stock [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Preferred Stock, Convertible, Shares Issuable                     872,766  
Common Stock [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Preferred Stock, Convertible, Shares Issuable                     872,766  
Employees [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Share-based Payment Arrangement, Expense                     $ 769,479  
Unamortized stock option expense                     255,277  
Non-Employees [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Share-based Payment Arrangement, Expense                       $ 749,277
Unamortized stock option expense                     $ 1,931,853  
Unamortized stock compensation term                     3 years 2 months 23 days  
Share-based Payment Arrangement, Option [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Number of option shares issued                     583,000 1,762,495
Share-based Payment Arrangement, Expense                     $ 1,518,756 $ 1,427,084
Share-based Payment Arrangement, Option [Member] | Settlement of Accrued Compensation [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Number of option shares issued 5,000 32,000 180,000                  
Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 1.96 $ 2.09 $ 3.65       $ 5.60          
Share-based Payment Award, Options, Vested in Period, Fair Value $ 9,615 $ 65,626 $ 474,231       $ 2,009,063          
Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 10 years 10 years 10 years                  
Share-based Payment Arrangement, Option [Member] | Options Vested Over 48 Months [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares         16,000              
Option vest monthly         350,000              
Share-based Payment Arrangement, Option [Member] | General and Administrative Expense [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Share-based Payment Arrangement, Expense                     1,513,835 1,354,750
Share-based Payment Arrangement, Option [Member] | Research and Development Expense [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Share-based Payment Arrangement, Expense                     4,921 $ 72,334
Share-based Payment Arrangement, Option [Member] | Minimum [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price                       $ 1.96
Share-based Payment Arrangement, Option [Member] | Minimum [Member] | Settlement of Accrued Compensation [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term             5 years          
Share-based Payment Arrangement, Option [Member] | Maximum [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price                       $ 5.60
Share-based Payment Arrangement, Option [Member] | Maximum [Member] | Settlement of Accrued Compensation [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term             10 years          
Share-based Payment Arrangement, Option [Member] | 5 Individuals [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Number of option shares issued         366,000              
Share-based Payment Arrangement, Option [Member] | Related Parties [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Number of option shares issued             350,000          
Equity Option [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Unamortized stock option expense                     $ 2,187,130  
Warrant [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Stock issued during the period exercised                 1,008,137      
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number                     6,132,630  
Class of warrant or right, outstanding, weighted average exercise price                     $ 3.38  
Class of warrant or right, outstanding, intrinsic value                     $ 928,802  
Warrants outstanding                   373,042    
Proceeds from warrants exercised                   $ 27,125    
IPO [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Stock Issued During Period, Shares, New Issues       3,180,000                
Number of Securities Called by Warrants or Rights       3,180,000                
IPO [Member] | Underwriter [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Stock Issued During Period, Shares, New Issues       79,500                
IPO [Member] | 45-day Option [Member]                        
Subsidiary, Sale of Stock [Line Items]                        
Number of Securities Called by Warrants or Rights       477,000